Time to all-cause discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia

被引：0
|
作者：
Swartz, MS
Ascher-Svanum, H
Faries, DE
Tunis, SL
Landbloom, R
Swanson, J
机构：
[1] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA
[2] Eli Lilly & Co, Outcomes Res, Indianapolis, IN 46285 USA
[3] Eli Lilly & Co, Neurosci, Indianapolis, IN 46285 USA
来源：
BIOLOGICAL PSYCHIATRY | 2005年 / 57卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
153
引用
收藏
页码：44S / 44S
页数：1
相关论文
共 50 条
  • [1] Time to all-cause discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
    Swartz, M
    Zhu, B
    Ascher-Svanum, H
    Faries, D
    Tunis, S
    Landbloom, R
    Swanson, J
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 551 - 552
  • [2] Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
    Haya Ascher-Svanum
    Baojin Zhu
    Douglas Faries
    Ron Landbloom
    Marvin Swartz
    Jeff Swanson
    BMC Psychiatry, 6
  • [3] Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
    Ascher-Svanum, Haya
    Zhu, Baojin
    Faries, Douglas
    Landbloom, Ron
    Swartz, Marvin
    Swanson, Jeff
    BMC PSYCHIATRY, 2006, 6 (1)
  • [4] Differences among antipsychotics in the time to all-cause drug discontinuation: Results from a longitudinal naturalistic study of schizophrenia
    Zhu, B
    Ascher-Svanum, H
    Faries, D
    Gibson, J
    Ernst, F
    Swartz, M
    VALUE IN HEALTH, 2003, 6 (03) : 349 - 349
  • [5] ALL-CAUSE TREATMENT DISCONTINUATION FOR OLANZAPINE COMPARED TO OTHER ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA: A META-ANALYSIS
    Soares-Weiser, K.
    Bechard-Evans, L.
    Lawson, A. H.
    Davis, J.
    Ascher-Svanum, H.
    VALUE IN HEALTH, 2010, 13 (03) : A106 - A106
  • [6] All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics - An integrated analysis
    Beasley, Charles M., Jr.
    Stauffer, Virginia L.
    Liu-Seifert, Hong
    Taylor, Cindy C.
    Dunayevich, Eduardo
    Davis, John M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (03) : 252 - 258
  • [7] Time to all-cause treatment discontinuation of olanzapine compared to other antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
    Soares-Weiser, Karla
    Bechard-Evans, Laura
    Lawson, Anthony Howard
    Davis, John
    Ascher-Svanum, Haya
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (02) : 118 - 125
  • [8] Longer time to all-cause antipsychotic discontinuation is associated with better schizophrenia treatment outcomes
    Dunayevich, E
    Zhao, FY
    Ascher-Svanum, H
    Mitchell, CP
    Phillips, GA
    Dellva, MA
    Green, A
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 107S - 107S
  • [9] Longer time to all-cause antipsychotic discontinuation is associated with better schizophrenia treatment outcomes
    Dunayevich, E
    Zhao, F
    Ascher-Svanum, H
    Mitchell, C
    Phillips, G
    Dellva, MA
    Green, A
    EUROPEAN PSYCHIATRY, 2005, 20 : S95 - S96
  • [10] Typical versus atypical antipsychotics in first episode schizophrenia
    Altamura, AC
    Sassella, F
    Bassetti, R
    Mundo, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S35 - S35
12345